Literature DB >> 22129472

The Arabic allele: a single base pair substitution activates a 10-base downstream cryptic splice acceptor site in exon 12 of LDLR and severely decreases LDLR expression in two unrelated Arab families with familial hypercholesterolemia.

Said M Shawar1, Mohammad A Al-Drees, Ahmad R Ramadan, Najat H Ali, Suad M Alfadhli.   

Abstract

Familial hypercholesterolemia (FH) is a monogenic autosomal dominant disorder caused by defects in LDLR. Few reports describe FH mutations among Arabs. We describe a mutation in LDLR of two unrelated Arab families. We investigated 19 patients using DNA sequencing, RFLP, and real-time (RT) PCR. DNA sequencing showed a base pair substitution (c.1706-2 A>T) in the splice acceptor site of LDLR intron 11. Our results were confirmed by RFLP on 2% agarose gel. In silico analysis predicted a new cryptic splice site downstream of the original position generating a 10-base deletion from the beginning of exon 12; (c.1706-1715del.ATCTCCTCAG). cDNA sequencing of exon 12 confirmed the computational analysis. The deletion was visualized on 4% agarose gel. The deletion generates a frameshift and a premature termination codon (c.1991-1993; p.(Asp569Valfs*93). RT-PCR revealed that LDLR mRNA is 9.3%±6.5 and 17.9%±8.0 for FH homozygote and heterozygote individuals respectively, compared to a healthy family control. We predict a class II LDLR mutation that leads to a truncated receptor missing exons 14-18. We called this mutation "the Arabic allele". We expect a significant contribution of this mutation to the prevalence of FH among Arabs. Also, we propose that the severe down regulation of LDLR mRNA expression is due to nonsense-mediated-decay.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22129472     DOI: 10.1016/j.atherosclerosis.2011.10.045

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

1.  Dyslipidemia in the Arabian Gulf and its Impact on Cardiovascular Risk Outcome.

Authors:  Khalid Al-Rasadi; Hilal Al-Sabti
Journal:  Oman Med J       Date:  2015-11

2.  Relationships of LDLR genetic polymorphisms with cerebral infarction: a meta-analysis.

Authors:  Hai-Cheng Yan; Wei Wang; Chang-Wu Dou; Fu-Ming Tian; Song-Tao Qi
Journal:  Mol Biol Rep       Date:  2014-03-05       Impact factor: 2.316

3.  Hypercholesterolemia among apparently healthy university students.

Authors:  Said M Shawar; Neda A Al-Bati; Ali Al-Mahameed; Das S Nagalla; Mohammed Obeidat
Journal:  Oman Med J       Date:  2012-07

4.  The Prevalence and Genetic Spectrum of Familial Hypercholesterolemia in Qatar Based on Whole Genome Sequencing of 14,000 Subjects.

Authors:  Ilhame Diboun; Yasser Al-Sarraj; Salman M Toor; Shaban Mohammed; Nadeem Qureshi; Moza S H Al Hail; Amin Jayyousi; Jassim Al Suwaidi; Omar M E Albagha
Journal:  Front Genet       Date:  2022-07-15       Impact factor: 4.772

5.  The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results.

Authors:  Khalid Al-Rasadi; Khalid F Alhabib; Faisal Al-Allaf; Khalid Al-Waili; Ibrahim Al-Zakwani; Ahmad AlSarraf; Wael Almahmeed; Nasreen AlSayed; Mohammad Alghamdi; Mohammed A Batais; Turky H Almigbal; Fahad Alnouri; Abdulhalim Kinsara; Ashraf Hammouda; Zuhier Awan; Heba Kary; Omer A Elamin; Fahad Zadjali; Mohammed Al-Jarallah; Abdullah Shehab; Hani Sabbour; Haitham Amin; Hani Altaradi
Journal:  Curr Vasc Pharmacol       Date:  2020       Impact factor: 2.719

6.  Establishing the Mutational Spectrum of Hungarian Patients with Familial Hypercholesterolemia.

Authors:  László Madar; Lilla Juhász; Zsuzsanna Szűcs; Lóránt Kerkovits; Mariann Harangi; István Balogh
Journal:  Genes (Basel)       Date:  2022-01-15       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.